nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—CFTR—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.108	0.14	CbGpPWpGaD
Bumetanide—CFTR—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.096	0.124	CbGpPWpGaD
Bumetanide—SLC22A8—optic choroid—age related macular degeneration	0.0461	0.202	CbGeAlD
Bumetanide—PTGS2—Nicotinate metabolism—NMNAT1—age related macular degeneration	0.0434	0.0562	CbGpPWpGaD
Bumetanide—SLC12A5—eye—age related macular degeneration	0.0333	0.146	CbGeAlD
Bumetanide—SLC12A5—retina—age related macular degeneration	0.033	0.145	CbGeAlD
Bumetanide—SLC12A4—eye—age related macular degeneration	0.0276	0.121	CbGeAlD
Bumetanide—SLC12A4—retina—age related macular degeneration	0.0274	0.12	CbGeAlD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0197	0.0256	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0197	0.0256	CbGpPWpGaD
Bumetanide—SLC12A2—eye—age related macular degeneration	0.0191	0.0836	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0168	0.0217	CbGpPWpGaD
Bumetanide—CA12—eye—age related macular degeneration	0.0139	0.0609	CbGeAlD
Bumetanide—CA12—connective tissue—age related macular degeneration	0.0134	0.0587	CbGeAlD
Bumetanide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—age related macular degeneration	0.0132	0.0171	CbGpPWpGaD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0131	0.017	CbGpPWpGaD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0119	0.0154	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0113	0.0146	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0113	0.0146	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0113	0.0146	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.01	0.013	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.01	0.013	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.01	0.013	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.01	0.013	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.01	0.013	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.01	0.013	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.01	0.0129	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00998	0.0129	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00957	0.0124	CbGpPWpGaD
Bumetanide—SLC22A8—eye—age related macular degeneration	0.00928	0.0407	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00853	0.011	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00853	0.011	CbGpPWpGaD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.00834	0.0108	CbGpPWpGaD
Bumetanide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT1—age related macular degeneration	0.0083	0.0108	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00596	0.00771	CbGpPWpGaD
Bumetanide—CA9—Cellular response to hypoxia—VEGFA—age related macular degeneration	0.00581	0.00753	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00569	0.00737	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00543	0.00704	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0054	0.007	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—CRP—age related macular degeneration	0.00529	0.00685	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00507	0.00657	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00507	0.00657	CbGpPWpGaD
Bumetanide—PTGS2—connective tissue—age related macular degeneration	0.00507	0.0222	CbGeAlD
Bumetanide—PTGS2—S1P1 pathway—KDR—age related macular degeneration	0.00507	0.00656	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00495	0.00642	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00495	0.00642	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00495	0.00642	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00454	0.00588	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00421	0.00546	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00403	0.00522	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NMNAT1—age related macular degeneration	0.00393	0.00509	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NMNAT1—age related macular degeneration	0.00383	0.00496	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00379	0.00491	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NMNAT1—age related macular degeneration	0.00358	0.00463	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NMNAT1—age related macular degeneration	0.00358	0.00463	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ELOVL4—age related macular degeneration	0.00344	0.00445	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0034	0.0044	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ELOVL4—age related macular degeneration	0.00335	0.00434	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NMNAT1—age related macular degeneration	0.00331	0.00429	CbGpPWpGaD
Bumetanide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.0032	0.00415	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ELOVL4—age related macular degeneration	0.00313	0.00405	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ELOVL4—age related macular degeneration	0.00313	0.00405	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00308	0.00399	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00303	0.00392	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00303	0.00392	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ELOVL4—age related macular degeneration	0.0029	0.00375	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00289	0.00374	CbGpPWpGaD
Bumetanide—PTGS2—S1P1 pathway—VEGFA—age related macular degeneration	0.00279	0.00362	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SLC16A8—age related macular degeneration	0.00277	0.00359	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NMNAT1—age related macular degeneration	0.00277	0.00359	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00275	0.00356	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00275	0.00356	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SLC16A8—age related macular degeneration	0.0027	0.0035	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00267	0.00346	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00267	0.00346	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NMNAT1—age related macular degeneration	0.00264	0.00342	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00259	0.00335	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SLC16A8—age related macular degeneration	0.00252	0.00326	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SLC16A8—age related macular degeneration	0.00252	0.00326	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00251	0.00325	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ELOVL4—age related macular degeneration	0.00242	0.00314	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC16A8—age related macular degeneration	0.00233	0.00302	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ELOVL4—age related macular degeneration	0.00231	0.00299	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00231	0.00299	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00231	0.00299	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0023	0.00298	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00224	0.0029	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00216	0.0028	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00216	0.0028	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NMNAT1—age related macular degeneration	0.00213	0.00277	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00205	0.00265	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00205	0.00265	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC16A8—age related macular degeneration	0.00195	0.00253	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00193	0.0025	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00193	0.0025	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ELOVL4—age related macular degeneration	0.00187	0.00242	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC16A8—age related macular degeneration	0.00186	0.00241	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0017	0.0022	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00161	0.00209	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00155	0.00201	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00152	0.00197	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC16A8—age related macular degeneration	0.0015	0.00195	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00149	0.00194	CbGpPWpGaD
Bumetanide—CA14—Metabolism—LIPC—age related macular degeneration	0.00142	0.00184	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—LIPC—age related macular degeneration	0.00138	0.00179	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00138	0.00178	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CETP—age related macular degeneration	0.00137	0.00177	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NMNAT1—age related macular degeneration	0.00136	0.00176	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00136	0.00176	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CETP—age related macular degeneration	0.00133	0.00173	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.0013	0.00168	CbGpPWpGaD
Bumetanide—CA7—Metabolism—LIPC—age related macular degeneration	0.00129	0.00167	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—LIPC—age related macular degeneration	0.00129	0.00167	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00128	0.00165	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CETP—age related macular degeneration	0.00124	0.00161	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CETP—age related macular degeneration	0.00124	0.00161	CbGpPWpGaD
Bumetanide—CA12—Metabolism—LIPC—age related macular degeneration	0.00119	0.00155	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ELOVL4—age related macular degeneration	0.00119	0.00154	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TLR4—age related macular degeneration	0.00118	0.00152	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CETP—age related macular degeneration	0.00115	0.00149	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00115	0.00149	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00114	0.00148	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.0011	0.00143	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00106	0.00138	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00101	0.00131	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CCL2—age related macular degeneration	0.00101	0.00131	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—LIPC—age related macular degeneration	0.000999	0.00129	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NMNAT1—age related macular degeneration	0.000982	0.00127	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RDH8—age related macular degeneration	0.000982	0.00127	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CETP—age related macular degeneration	0.000964	0.00125	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC16A8—age related macular degeneration	0.00096	0.00124	CbGpPWpGaD
Bumetanide—CA4—Metabolism—LIPC—age related macular degeneration	0.000953	0.00123	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000951	0.00123	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CETP—age related macular degeneration	0.000919	0.00119	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VEGFA—age related macular degeneration	0.000882	0.00114	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPE65—age related macular degeneration	0.000859	0.00111	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NMNAT1—age related macular degeneration	0.000823	0.00107	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CD36—age related macular degeneration	0.000822	0.00106	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CD36—age related macular degeneration	0.000801	0.00104	CbGpPWpGaD
Bumetanide—CA9—Metabolism—LIPC—age related macular degeneration	0.00077	0.000997	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CD36—age related macular degeneration	0.000748	0.000969	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CD36—age related macular degeneration	0.000748	0.000969	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CETP—age related macular degeneration	0.000743	0.000962	CbGpPWpGaD
Bumetanide—CA14—Metabolism—APOE—age related macular degeneration	0.000725	0.000939	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ELOVL4—age related macular degeneration	0.000719	0.000932	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—APOE—age related macular degeneration	0.000707	0.000915	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CD36—age related macular degeneration	0.000693	0.000897	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ABCA4—age related macular degeneration	0.000692	0.000897	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000666	0.000863	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—APOE—age related macular degeneration	0.00066	0.000855	CbGpPWpGaD
Bumetanide—CA7—Metabolism—APOE—age related macular degeneration	0.00066	0.000855	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000643	0.000833	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00064	0.000829	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOE—age related macular degeneration	0.000611	0.000792	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RHO—age related macular degeneration	0.000602	0.00078	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC16A8—age related macular degeneration	0.00058	0.000751	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CD36—age related macular degeneration	0.000579	0.00075	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000564	0.000731	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CD36—age related macular degeneration	0.000552	0.000716	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOE—age related macular degeneration	0.000511	0.000662	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LIPC—age related macular degeneration	0.000491	0.000637	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOE—age related macular degeneration	0.000487	0.000631	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CETP—age related macular degeneration	0.000474	0.000614	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CD36—age related macular degeneration	0.000446	0.000578	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000441	0.000571	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOE—age related macular degeneration	0.000394	0.00051	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000386	0.0005	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CST3—age related macular degeneration	0.000376	0.000488	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000341	0.000442	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFBR1—age related macular degeneration	0.000338	0.000438	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LIPC—age related macular degeneration	0.000297	0.000384	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CETP—age related macular degeneration	0.000286	0.000371	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD36—age related macular degeneration	0.000285	0.000369	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOE—age related macular degeneration	0.000251	0.000326	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOE—age related macular degeneration	0.000181	0.000235	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD36—age related macular degeneration	0.000172	0.000223	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOE—age related macular degeneration	0.000152	0.000197	CbGpPWpGaD
